GFAP and neuromyelitis optica: NMO is characterized pathologically by a significant loss of immunoreactivity for the astrocytic proteins AQP4 and glial fibrillary acidic protein (GFAP), perivascular deposition of immunoglobulins, and complement activation, even in lesions containing some myelin [47].